Cargando…

Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study

OBJECTIVE: To evaluate the extent of hydroxychloroquine-induced corrected QT (QTc) prolongation and its relation to COVID-19 infection severity and incidence of polymorphic ventricular arrhythmias and sudden arrhythmic deaths. DESIGN: A large-scale cohort study with retrospective analysis of baselin...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Kadri, Moutaz, Al Falasi, Omar, Ahmed, Rizwan, Al Awadhi, Ahlam, Altaha, Zainab, Hillis, Amany, Panikkaveetil, Basheer, Abdalla, Sara, Ansel Benette, Honey, Almubarak, Adhba, Saifuddin, Mohammed, Alattar, Yousef, Oulhaj, Abderrahim, AlKaabi, Salem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829836/ https://www.ncbi.nlm.nih.gov/pubmed/35140148 http://dx.doi.org/10.1136/bmjopen-2021-051579

Ejemplares similares

Hydroxychloroquine: QTc prolongation: case report.
Publicado: (2020)

Hydroxychloroquine: QTc prolongation: 2 case reports
Publicado: (2021)

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Long QTc syndrome and hypoglycaemia: 3 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Medication Adherence Among Patients with Multimorbidity in the United Arab Emirates
por: Allaham, Kholoud K, et al.
Publicado: (2022)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
por: O'Laughlin, John P., et al.
Publicado: (2016)

Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis
por: Agstam, Sourabh, et al.
Publicado: (2020)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
por: Hor, Chee Peng, et al.
Publicado: (2020)

Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
por: Park, Elizabeth, et al.
Publicado: (2021)

Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients
por: Park, Elizabeth, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine: Persistent increase in QTc interval following off-label use: case report
Publicado: (2022)

Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon
por: Ayo Bivigou, Elsa, et al.
Publicado: (2022)

Reinduction of Bevacizumab in Combination with Pegylated Liposomal Doxorubicin in a Patient with Recurrent Glioblastoma Multiforme Who Progressed on Bevacizumab/Irinotecan
por: Almubarak, Mohammed, et al.
Publicado: (2008)

The Psychological Impact of Isolation on Hospitalised Patients with COVID-19 Infection in the UAE
por: Ahmed, Nahida Nayaz, et al.
Publicado: (2022)

The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)

Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis
por: Arfaras-Melainis, Angelos, et al.
Publicado: (2021)

Potential for native hydrocarbon-degrading bacteria to remediate highly weathered oil-polluted soils in Qatar through self-purification and bioaugmentation in biopiles
por: AlKaabi, Nasser, et al.
Publicado: (2020)

Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study
por: Al-Shamsi, Saif, et al.
Publicado: (2019)

Hydroxychloroquine: Right bundle branch block and QTc prolongation following off label use: case report
Publicado: (2020)

Cryptosporidium parvum and other enteric pathogens in scouring neonatal dairy calves from the Al Ain region, United Arab Emirates
por: Mohteshamuddin, Khaja, et al.
Publicado: (2020)

A clinical risk score to predict in-hospital mortality in critically ill patients with COVID-19: a retrospective cohort study
por: Alkaabi, Salem, et al.
Publicado: (2021)

Hydroxychloroquine: Non-sustained monomorphic ventricular tachycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
por: Grewal, Sarah, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with COVID-19 Treated with Hydroxychloroquine
por: Asli, Rosmonaliza, et al.
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Vomiting and QTc-interval prolongation following off-label therapy: 2 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efum3mctev7r54ela42i16bdj3